Radiolabeled iodobenzamide

N/A

Report date: 2025/12/01 17:16:36
NME

Base Information

Drug NameRadiolabeled iodobenzamide
Drug Alias Name123I-iodobenzamide
ClassificationDiagnostic agent (In vivo)Small moleculesRadiation-emitting products > Radioactive diagnostic agent +[5
Mechanisms of ActionSingle-photon emission-computed tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsParkinson DiseaseMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsParkinson DiseaseMelanoma

Other Information

ATC CodeN/A
Related LinksN/A